Evidence map›Paper›PMID 25695873›Full record

ArticleAIDS (London, England)2015

Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.

Martyn A French, Alessandro Cozzi-Lepri, Roberto C Arduino, Margaret Johnson, Amit C Achhra, Alan Landay, INSIGHT SMART Study Group

Abstract read
In one paragraph

Article in AIDS (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. ART Regimen and Other Sociodemographics Do Not Affect Cytokine Expression in HIV Patients in Ghana.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Atypical Skeletal Muscle Profiles in Human Immunodeficiency Virus-Infected Asymptomatic Middle-Aged Adults.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Martyn A FrenchaSchool of Pathology and Laboratory Medicine, University of Western Australia bDepartment of Clinical Immunology, Royal Perth Hospital and PathWest, Laboratory Medicine, Perth, Australia cResearch Department of Infection and Population Health, University College London, London, United Kingdom dHouston AIDS Research Team, Division of Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, USA eHIV Clinic and Department of Respiratory Medicine, Royal Free Hospital, London, United Kingdom fKirby Institute, University of New South Wales, Sydney, Australia gDepartment of Immunology and Microbiology, Rush University Medical Center, Chicago, USA.
Alessandro Cozzi-Lepri
Roberto C Arduino
Margaret Johnson
Amit C Achhra
Alan Landay
INSIGHT SMART Study Group
Royal Perth Hospital · AURush University Medical Center · USThe University of Texas Health Science Center at Houston · USUniversity College London · GBUNSW Sydney · AU

Funding

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)U01AI068641 · NIAID · UNIVERSITY OF MINNESOTA · PI NEATON, JAMES DENNIS · 2006 to 2010
$120.1M
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)UM1AI068641 · NIAID · UNIVERSITY OF MINNESOTA · PI NEATON, JAMES DENNIS · 2011 to 2014
$83.5M
COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDSU01AI046362 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI GORDIN, FRED M · 2000 to 2006
$75.9M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
NCATS NIH HHS UL1 TR000371NIAID NIH HHS U01 AI046362NIAID NIH HHS U01-AI046362NIAID NIH HHS UM1 AI068641NIAID NIH HHS UM1-AI068641PHS HHS U01-A1042170
6 · The paper itself

Abstract

backgroundAll-cause mortality and serious non-AIDS events (SNAEs) in individuals with HIV-1 infection receiving antiretroviral therapy are associated with increased production of interleukin-6 which appears to be driven by monocyte/macrophage activation. Plasma levels of other cytokines or chemokines associated with immune activation might also be biomarkers of an increased risk of mortality and/or SNAEs.

methodsBaseline plasma samples from 142 participants enrolled into the Strategies for Management of Antiretroviral Therapy study, who subsequently died, and 284 matched controls, were assayed for levels of 15 cytokines and chemokines. Cytokine and chemokine levels were analysed individually and when grouped according to function (innate/proinflammatory response, cell trafficking and cell activation/proliferation) for their association with the risk of subsequent death.

resultsHigher plasma levels of proinflammatory cytokines (interleukin-6 and tumour necrosis factor-α) were associated with an increased risk of all-cause mortality but in analyses adjusted for potential confounders, only the association with interleukin-6 persisted. Increased plasma levels of the chemokine CXCL8 were also associated with all-cause mortality independently of hepatitis C virus status but not when analyses were adjusted for all confounders. In contrast, higher plasma levels of cytokines mediating cell activation/proliferation were not associated with a higher mortality risk and exhibited a weak protective effect when analysed as a group.

conclusionWhereas plasma levels of interleukin-6 are the most informative biomarker of cytokine dysregulation associated with all-cause mortality in individuals with HIV-1 infection, assessment of plasma levels of CXCL8 might provide information about causes of mortality and possibly SNAEs.

Indexed as

BiomarkersCase-Control StudiesClinical Trials as TopicCytokinesFemaleHIV InfectionsHumansMalePrognosisRisk AssessmentSurvival AnalysisBiomarkersCytokines

Identifiers

PMID25695873
PMCPMC4439268
OpenAlexW1979834219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.